Advertisements Of Health Products Promoted On TV

New Delhi : Minister of Information and Broadcasting; and Minister of Youth Affairs and sports Anurag Singh Thakur replied on 21.3.2023 in a Starred question No. 288 of Sanjay Sadashivrao Mandlik and Dhairyasheel Sambhajirao Mane in Lok Sabha that “Advertising Standards Council of India (ASCI) is a nonstatutory, non-Governmental, voluntary self-regulation organization of the advertising industry. Its report, guidelines etc. are available on its website i.e. https://ascionline.in/.

All advertisements telecast on private satellite TV channels are required to adhere to the Advertising Code prescribed under the Cable Television Networks (Regulation) Act, 1995 and rules framed thereunder.

For print media the Press Council of India (PCI), a statutory body established under the Press Council Act, 1978, has issued norms relating to advertisements in its ‘Norms for Journalistic Conduct’. PCI has a complaint mechanism for redressing complaints.

A Central Consumer Protection Authority (CCPA) has been established under the provisions of Consumer Protection Act, 2019 w.e.f. 24.07.2020 which inter-alia looks into misleading advertisements either suo-moto or on complaints or on directions from the Central Government. CCPA has notified ‘Guidelines for Prevention of Misleading Advertisements and Endorsements for Misleading Advertisements, 2022’ on 9th June, 2022.”

Earlier the minister replied in Unstarred Question No. 1844 answered on 22.12.2022 that “Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder provides for prohibition of misleading advertisements and exaggerated claims of drugs and medicinal substances (including AYUSH medicines). The Central Government has notified Rule 170 in the Drugs & Cosmetics Rules, 1945 on 24th December, 2018 specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines. An institutional mechanism at the central and state levels have been set up for enforcement and taking action in case of violation.”

Ramdev-promoted FMCG company Patanjali Ayurved’s advertising promotional expenses for the fiscal ended 31st March 2021 has increased 3.26% to Rs 294.09 crore from Rs 284.79 crore in the previous fiscal, according to financial data accessed by business intelligence platform.
  • Related Posts

    • Pharma
    • June 23, 2025
    • 114 views
    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    LONDON:  Ananda Pharma PLC (AQSE:ANA, OTCQB: ANANF) has manufactured 40 liters of its lead investigational product MRX1 and 40 liters of matched placebo in compliance with pharmaceutical Good Manufacturing Practices…

    • Pharma
    • June 23, 2025
    • 141 views
    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Hyderabad:  In a ray of hope for HIV patients, particularly for the significant burden in the two-Telugu speaking States of Telangana and Andhra Pradesh, several India pharmaceutical companies have secured…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ananda Pharma completes GMP manufacturing of MRX1 for clinical trials

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug

    Drug licences of 9 pharma dealers suspended in Jammu

    Drug licences of 9 pharma dealers suspended in Jammu

    Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC

    Sun Pharma Gets Relief on Packaging Norms for Pantoprazole-Levosulpiride FDC